According to Merck's latest financial reports the company has $46.05 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $46.05 B | 20.39% |
2021-12-31 | $38.25 B | 50.59% |
2020-12-31 | $25.40 B | -2.3% |
2019-12-31 | $26.00 B | -3.28% |
2018-12-31 | $26.88 B | -22.24% |
2017-12-31 | $34.56 B | -14.24% |
2016-12-31 | $40.30 B | -9.96% |
2015-12-31 | $44.76 B | -8.25% |
2014-12-31 | $48.79 B | -6.76% |
2013-12-31 | $52.32 B | -5.66% |
2012-12-31 | $55.46 B | -2.6% |
2011-12-31 | $56.94 B | 0.24% |
2010-12-31 | $56.80 B | -7.62% |
2009-12-31 | $61.49 B | 190.51% |
2008-12-31 | $21.16 B | 2.8% |
2007-12-31 | $20.59 B | 3.13% |
2006-12-31 | $19.96 B | -1.76% |
2005-12-31 | $20.32 B | 3.19% |
2004-12-31 | $19.69 B | 1.04% |
2003-12-31 | $19.49 B | -15.73% |
2002-12-31 | $23.12 B | 10.73% |
2001-12-31 | $20.88 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $76.80 B | 66.75% | ๐บ๐ธ USA |
![]() Novartis NVS | $52.14 B | 13.21% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $95.91 B | 108.25% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $36.90 B | -19.87% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $11.29 B | -75.48% | ๐บ๐ธ USA |
![]() Amgen AMGN | $5.34 B | -88.39% | ๐บ๐ธ USA |
![]() Sanofi SNY | $80.48 B | 74.75% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | $31.88 B | -30.77% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $14.01 B | -69.58% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | $8.69 B | -81.13% | ๐ฎ๐ฑ Israel |